DDI Study of Evobrutinib and Carbamazepine
Clinical trial NCT05248945 · COMPLETED
Trial details
- NCT number
- NCT05248945
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-13
- Primary completion
- 2022-07-18
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.